An interventional study of Mouthwash for delicate gums in Gingivitis, sponsored by Lacer S.A.. Completed at 1 site in Spain. Open to participants aged 18 Years to 65 Years, including healthy volunteers. Per ClinicalTrials.gov, last updated 2026-08-26.
Sponsored by Lacer S.A. (part of Italfarmaco) · Not applicable, Interventional, and Other
Help build ClinicalTrials.gg — short surveys, remote interviews or testing, in your language. Take part →
Among 15 studies in Gingivitis with a site in Spain — 2 open to participants now, 2 under way, none of them phase 3. Gingivitis · Spain.
Among the 15 studies in Gingivitis with a site in Spain, this one is the 9th largest by enrollment of the 13 interventional ones that give a count, is one of 4 that started in 2026, is one of 6 with no phase, and was the 13th registered.
636 studies on the registry are indexed under Gingivitis; 109 are open to participants now.
Browse Gingivitis studies →2 of the 15 studies in Gingivitis with a site in Spain are open now. Recruiting first, the newest first:
Universidad de Murcia · Sites in Spain
Ages 18–40
Aesculap AG · Sites in Spain
Ages 18+
A study can be open while its sites in Spain have not opened yet or have stopped. Only those recruiting at a site in Spain →
Of the 54 Gingivitis studies recruiting now, 16 (30%) set no upper age limit and 36 (67%) stop at 75 or younger; 11 take children under 18; 36 take healthy volunteers.
This study: 18 Years to 65 Years · all sexes · healthy volunteers too.
The full table on the hub →This tab as a report to print or save as PDF → With an account.
15 studies; the count open now beside each. This study's row is marked.
A study in two phases is counted once above. Listed by phase, each with its combined phases: Phase 1 1 · Phase 2 2 · Phase 3 3 · Phase 4 2
First in 2007; this study’s year is marked. 4 started in 2026.
By drug class, each counting the studies that test any of its medicines:
This study's enrollment of 33 is below the median of 66 across 512 interventional studies indexed under Gingivitis.
Median enrollment 60 across the 13 interventional studies, 100 across the 2 observational. Of the 12 that completed or were terminated, 1 (8%) have results posted.
This tab as a report to print or save as PDF → With an account.
6 of 15 have an industry lead sponsor. The 10 most frequent:
This study is registered under Lacer S.A., one of the names counted as Italfarmaco. Under that name alone:
Lacer S.A. is the lead sponsor of 13 studies on the registry; 3 are open to participants now.
Italfarmaco has 2 studies filed under Gingivitis — fewer than ten, so there is no comparison to draw.
2 of the studies in Gingivitis with a site in Spain that are under way reach primary completion within a year, 0 of them phase 3. Phase 3 first, then by date:
| Study | Primary completion |
|---|---|
| NCT05813236Aesculap AGNOVOSYN® Quick Versus MONOSYN® Quick Suture Material in Resective Periodontal Surgery | 2026-11 |
| NCT07718061Universidad de MurciaBacterial Diversity Study Using 16S rRNA Sequencing of Periodontal Samples From Patients With Orthodontic Retainers | 2027-07 |
Add all 2 to your calendar (.ics) → With an account.
Among the 15 studies in Gingivitis with a site in Spain, from their registry updates:
This tab as a report to print or save as PDF → With an account.
The goal of this study is to learn if a mouthwash works to alleviate gingivitis in adults. It will also learn about the safety of the product. The main question it aims to answer is:
Participants will:
Go through the criteria one by one — yes, no or not sure — and take the list to your doctor or the study team. Kept in this browser only.
Subjects clinically showing moderate gums inflammation (gingivitis grade II, in particular all gingival scores for the mean should be between 1.75 and 2.3, according to Löe and Silness gingival scoring system), in particular:
Exclusion Criteria:
Underlined terms in the criteria open these too. Explained by clinicaltrials.gg, not part of the registry record. The study team decides who can take part.
A planned gap after a treatment, so that its effects can lessen before the study treatment or a study assessment. Ask the study team and the doctor who prescribed it before changing any medicine.
Able to become pregnant: from the first period until menopause, unless permanently unable to through surgery (removal of the womb, or of both ovaries or both fallopian tubes).
Criteria for people of childbearing potential usually ask for a negative pregnancy test and for contraception during the study and for a time after it.
Washout period
A planned gap after a treatment, so that its effects can lessen before the study treatment or a study assessment. Ask the study team and the doctor who prescribed it before changing any medicine.
Explained by clinicaltrials.gg, not part of the registry record. The study team decides who can take part.
Childbearing potential
Able to become pregnant: from the first period until menopause, unless permanently unable to through surgery (removal of the womb, or of both ovaries or both fallopian tubes).
Criteria for people of childbearing potential usually ask for a negative pregnancy test and for contraception during the study and for a time after it.
Explained by clinicaltrials.gg, not part of the registry record. The study team decides who can take part.
Mouthwash will be used 3 times a day after brushing during 4 weeks.
Other: Mouthwash for delicate gums
Mouthwash will be used 3 times a day after brushing during 4 weeks.
Change from Baseline in Gingival Index Score at 4 weeks
The score is from 0 (normal gum) to 4 (severe inflammation, swelling, bleeding and presence of ulcers).
Time frame: From enrolment to the end of use at 4 weeks.
Plan to share: No — Only summary of the results to support the publication will be shared. No complete study documents will shared
Ran from Mar 2026 to primary completion in Jul 2026, 4 months.
Of 53 industry-sponsored interventional studies with no phase under Gingivitis, half reached primary completion within 2 months of starting (the median), counting those still running; a quarter within 1 and three quarters within 5. This study's 4 months is above that.
Counting every sponsor, half of 260 studies reached it within 7 months; a quarter within 3 and three quarters within 15.
How these figures are worked out, and which studies are left out of them.
This study is completed, as verified in Apr 2026. You cannot join it, but the record below documents what was studied.
Get an email when the registry record changes — status, dates, results — or when someone posts here.
Sign in to followQuestions and observations about this study, from anyone following it. Not medical advice, and not a channel to the study team — their contact details are on the registry record.
Sign in to join the discussion. Reading takes no account; posting does. You choose a display name, and a pseudonym is the default.
Nothing here yet. If you are running this trial, taking part in it, or weighing whether to, this is the place to say so.